186 related articles for article (PubMed ID: 22956285)
1. Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation.
Milrot E; Jackman A; Flescher E; Gonen P; Kelson I; Keisari Y; Sherman L
Invest New Drugs; 2013 Apr; 31(2):333-44. PubMed ID: 22956285
[TBL] [Abstract][Full Text] [Related]
2. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin.
Milrot E; Jackman A; Kniazhanski T; Gonen P; Flescher E; Sherman L
Cancer Lett; 2012 Jun; 319(1):31-8. PubMed ID: 22198483
[TBL] [Abstract][Full Text] [Related]
3. Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells.
Kniazhanski T; Jackman A; Heyfets A; Gonen P; Flescher E; Sherman L
Cancer Lett; 2008 Nov; 271(1):34-46. PubMed ID: 18599197
[TBL] [Abstract][Full Text] [Related]
4. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.
Yeruva L; Hall C; Elegbede JA; Carper SW
Anticancer Drugs; 2010 Jan; 21(1):1-9. PubMed ID: 19820395
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate.
Ezekwudo D; Shashidharamurthy R; Devineni D; Bozeman E; Palaniappan R; Selvaraj P
Cancer Lett; 2008 Nov; 270(2):277-85. PubMed ID: 18573594
[TBL] [Abstract][Full Text] [Related]
6. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.
Raviv Z; Zilberberg A; Cohen S; Reischer-Pelech D; Horrix C; Berger MR; Rosin-Arbesfeld R; Flescher E
Br J Pharmacol; 2011 Nov; 164(5):1433-44. PubMed ID: 21486277
[TBL] [Abstract][Full Text] [Related]
7. Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis.
Ofer K; Gold D; Flescher E
Int J Parasitol; 2008 Jul; 38(8-9):959-68. PubMed ID: 18294640
[TBL] [Abstract][Full Text] [Related]
8. Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
Cohen S; Flescher E
Phytochemistry; 2009 Sep; 70(13-14):1600-9. PubMed ID: 19660769
[TBL] [Abstract][Full Text] [Related]
9. Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines.
Tong QS; Jiang GS; Zheng LD; Tang ST; Cai JB; Liu Y; Zeng FQ; Dong JH
Anticancer Drugs; 2008 Jul; 19(6):573-81. PubMed ID: 18525316
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of cervical cancer cell lines to low-dose radiation by retinoic acid does not require functional p53.
Tillmanns TD; Kamelle SA; Guruswamy S; Gould NS; Rutledge TL; Benbrook DM
Gynecol Oncol; 2005 Apr; 97(1):142-50. PubMed ID: 15790450
[TBL] [Abstract][Full Text] [Related]
11. Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block.
Gong XM; Zhang Q; Torossian A; Cao JP; Fu S
Int J Gynecol Cancer; 2012 Jun; 22(5):718-24. PubMed ID: 22552829
[TBL] [Abstract][Full Text] [Related]
12. Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14.
Zheng L; Li D; Xiang X; Tong L; Qi M; Pu J; Huang K; Tong Q
BMC Cancer; 2013 Feb; 13():74. PubMed ID: 23394613
[TBL] [Abstract][Full Text] [Related]
13. IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer.
Bruchim I; Sarfstein R; Reiss A; Flescher E; Werner H
Cancer Lett; 2014 Oct; 352(2):214-9. PubMed ID: 24997432
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
[TBL] [Abstract][Full Text] [Related]
15. Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells.
Yeruva L; Pierre KJ; Bathina M; Elegbede A; Carper SW
Cancer Invest; 2008 Nov; 26(9):890-9. PubMed ID: 18798057
[TBL] [Abstract][Full Text] [Related]
16. Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide.
Xiao XY; Jiang GS; Wang L; Lv L; Zeng FQ
Anticancer Drugs; 2011 Oct; 22(9):853-63. PubMed ID: 21642838
[TBL] [Abstract][Full Text] [Related]
17. Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose.
Heyfets A; Flescher E
Cancer Lett; 2007 Jun; 250(2):300-10. PubMed ID: 17125916
[TBL] [Abstract][Full Text] [Related]
18. AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis.
Jiang G; Zhao J; Xiao X; Tao D; Gu C; Tong Q; Luo B; Wang L; Zeng F
Cancer Lett; 2011 Mar; 302(1):37-46. PubMed ID: 21237556
[TBL] [Abstract][Full Text] [Related]
19. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study.
Segovia-Mendoza M; Jurado R; Mir R; Medina LA; Prado-Garcia H; Garcia-Lopez P
BMC Cancer; 2015 Jan; 15():21. PubMed ID: 25622528
[TBL] [Abstract][Full Text] [Related]
20. PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells.
Elia U; Flescher E
Neoplasia; 2008 Nov; 10(11):1303-13. PubMed ID: 18953440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
